Home > Medical Research Archives > Issue 149 > Thromboprophylaxis with nadroparin in the orthopaedic setting, a brief appraisal of the recent literature
Published in the Medical Research Archives
Feb 2018 Issue
Thromboprophylaxis with nadroparin in the orthopaedic setting, a brief appraisal of the recent literature
Published on Feb 15, 2018
DOI
Abstract
Low-molecular-weight heparins represent well-established agents for thromboprophylaxis in the orthopaedic and traumatological setting. The availability of different compounds requires the doctor to make a careful choice especially in the dose and duration of treatment, which represent two key factors for a successful therapy. In addition to the clinical benefit for the patient, an appropriate therapeutic choice allows the physician not to incur in medico-legal implications. In the present paper, we briefly review recent data from new trials in which nadroparin was used in patients after knee arthroscopy and lower leg plaster cast, and discuss the mode of use of the drug and the potential medico-legal implications.
Author info
Author Area
Have an article to submit?
Submission Guidelines
Submit a manuscript
Become a member
